Table 3.
Association of AFAP1-AS1 Expression (Δct) with the Clinicopathological Features of Patients
| Characteristics | Percentage of Case(NO) | Mean±SD | P value |
|---|---|---|---|
| Age(years) | 0.786 | ||
| ≥60 | 45.4 (44) | 17.55±2.76 | |
| <60 | 54.6 (53) | 17.69±2.206 | |
| Gender | 0.761 | ||
| Male | 75.3 (73) | 17.588±2.59 | |
| Female | 24.7 (24) | 17.765±2.03 | |
| Tumor location | 0.474 | ||
| Sinuses ventriculi | 28.9 (28) | 17.075±1.99 | |
| Cardia | 21.6 (21) | 17.863±2.25 | |
| Corpora ventriculi | 25.8 (25) | 18.102±2.58 | |
| Others | 23.7 (23) | 17.586±2.99 | |
| Diameter(cm) | 0.018 | ||
| ≥5 | 40.2 (39) | 18.34±2.56 | |
| <5 | 59.8 (58) | 17.15±2.29 | |
| Differentiation | 0.042 | ||
| Well | 2.1 (2) | 18.40±1.71 | |
| Moderate | 24.7 (24) | 17.21±3.01 | |
| Poor | 72.2 (70) | 17.65±2.15 | |
| Non | 1.0 (1) | 24.224±0 | |
| Invasion | 0.462 | ||
| T1+T2 | 16.5 (16) | 17.215±3.03 | |
| T3+T4 | 83.5 (81) | 17.71±2.34 | |
| Lymphatic metastasis | 0.430 | ||
| N0 | 26.8 (26) | 17.303±2.56 | |
| N1-3 | 73.2 (71) | 17.752±2.43 | |
| Venous invasion | 0.293 | ||
| Absent | 60.8 (59) | 17.42±2.44 | |
| Present | 39.2 (38) | 17.96±2.47 | |
| Perineural invasion(PNI) | 0.166 | ||
| Absent | 54.6 (53) | 17.31±2.42 | |
| Present | 45.4 (44) | 18.01±2.47 | |
| CEA | 0.056 | ||
| Normal | 83.5 (81) | 17.42±2.42 | |
| High | 16.5 (16) | 18.70±2.45 | |
| CA19-9 | 0.085 | ||
| Normal | 84.5 (82) | 17.447±2.47 | |
| High | 15.5 (15) | 18.640±2.28 | |
| AFP | 0.217 | ||
| Normal | 91.8 (89) | 17.53±2.49 | |
| High | 8.2 (8) | 18.66±1.95 | |
| CA-125 | 0.907 | ||
| Normal | 92.8 (90) | 17.623±2.47 | |
| High | 7.2 (7) | 17.73±2.52 |
Notes: The values set in boldface are considered statistically significant (p<0.05).
Abbreviation: AFAP1-AS1, actin filament associated protein 1 antisense RNA1.